ØFosun’s S&P Global CSA ESG score jumped from 56 points to 68 points, significantly ahead of the industry average of 29 points and making it among the top 6% of industries worldwide.ØFosun International received an MSCI ESG rating of AA for three consecutive years and was the only conglomerate in Greater China with such rating.Fosun International Limited (“Fosun Interna

Dear Fosuner,In the blink of an eye, 2023 is coming to an end. Thank you for your hard work and dedication.It has been a year of relentless efforts toward hope. After experiencing the three-year epidemic, many families have made plans for the new year from the beginning of the year and are eager to travel with their family. This year’s tourism rebound has been part

On the evening of 21 December, “Together For a Better Life · Fosun Holiday Night” Fosun Foundation 11th Anniversary Charity Ceremony was held at the Shanghai Symphony Hall to commend charitable individuals and enterprises of the year and unveil the launch of the Xin-Ling Guardianship Program (心玲守护), a program focusing on children’s mental health. Zhang Jiemin

Club Med, the pioneer of premium all-inclusive holiday experiences, proudly announced the official opening of Club Med Kiroro Grand. Nestled in the heart of Hokkaido's pristine Kiroro region, renowned for its record-breaking 21-metre snowfall and an extended 160-day winter, Club Med Kiroro Grand is poised to redefine Asia’s alpine holiday experience.The project&#x

On the evening of 15 December2023, local time in France, the Festival Dragons et Lanternes, the Chinese intangible cultural heritage event first being held overseas, officially opened to the public at the Jardin d'Acclimatation in Paris, France. Meanwhile, 9,300 kilometers away from the Jardin d'Acclimatation, Yuyuan Garden in Shanghai is ablaze wit

(Shanghai, China, 14 December 2023) The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced today that it will invest approximately US$3.3 million (approximately 500 million yen1) in a global multicenter Phase III clinical trial project (the "Program") led by Fosun Pharma for a triple artemisinin combination drug (Artemether-Lumefantrine-Amodiaquine fixed-

(13 December 2023) On 30 November 2023, the 2023 Forbes China ESG Innovative Enterprises Selection Summit and Award Ceremony Dinner was held in Shenzhen. Fosun International was rated as “2023 Forbes China ESG Innovative Enterprise” for its excellent performance in corporate growth, ESG practices, execution capability for innovation and industry influence.The rate

The Inaugural Fosun Health Conference on Guangdong-Hong Kong-Macao Healthcare Development Integration was successfully held in Hong Kong by Fosun Health on 12 December 2023. With the background of integrating medical services of Guangdong, Hong Kong and Macao, this year’s conference themed “Collaboration and Integration for Better Healthcare” aimed to facilitate bette

Shanghai, China, 12 December 2023 – Shanghai Henlius Biotech, Inc. (2696.HK) announced that the NDA for new indication of HANSIZHUANG, serplulimab, an innovative anti-PD-1 mAb independently developed by the company, in combination with chemotherapy as a first-line treatment for patients with locally advanced or metastatic non-squamous non-small cell lung can